Sustaining production while water resources are under pressure
All the news from Servier Group
Art and Patients: Showcasing art alongside medical research
5 Key things to know about World Heart Day
Empowering patients: an interview with Nicolas Garnier, Chief Patient Officer at Servier
Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder
World Leukemia Day: A global initiative to promote diagnosis
Servier and IDEAYA Biosciences Partner to Bring Darovasertib, a Promising Uveal Melanoma Treatment, to Patients Worldwide
Chronic venous disease: a complex condition with inconsistent treatment
Across the globe, Servier is taking action to promote therapeutic adherence